"And then, we discuss whether or not we're going to use a medical intervention," Basilico said, noting that some patients don't want to do a medical intervention
Source: Polaris Market Research Analysis Segmental Insights By Type of GLP-1 Agonist Drugs Analysis The segmentation, based on type of GLP-1 agonist drugs, includes long-acting GLP-1 agonist and short-acting GLP-1 agonist
doi: 10.1002/dmrr.2810 108 BarringtonPChienJYShowalterHDHSchneckKCuiSTibaldiFet al
Insurance covers GLP-1 medications, but coverage extent varies by your provider, location, and health circumstances
Why Tirzepatide May Lead to Greater Weight Loss The data isn't subtle
In a move to contain claims costs, many insurers no longer cover GLP-1 drugs for weight loss only, instead limiting access to patients with a diagnosis of diabetes